ホーム › 骨髄異形成症候群 › フロリダ州 › Miami
Miami、FLにおける骨髄異形成症候群の臨床試験
Miamiとその周辺地域（約30マイル以内）の拠点で、骨髄異形成症候群に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Miami Cancer Institute, Miami
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Miami Cancer Institute, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
被験者募集中第1/2相
- Sylvester Cancer Center - U Miami, Miami
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
被験者募集中第3相
- University of Miami, Miami
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
被験者募集中第2相健康なボランティア歓迎
- University of Miami, Miami
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Nicklaus Children's Hospital, Miami
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
被験者募集中第3相
- University of Miami Hospital and Clinics, Miami
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
被験者募集中第2相
- University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC), Miami
eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
被験者募集中
- University of Miami, Miami
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
被験者募集中第1/2相
- University of Miami, Miami
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
被験者募集中第2/3相
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
被験者募集中第1/2相
- University of Miami, Miami
- Miami Cancer Institute, Miami
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
被験者募集中
- Sylvester Comprehensive Cancer Center, Miami
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
被験者募集中第1相
- University of Miami Health System, Miami
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
被験者募集中第1相
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Miami
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
被験者募集中第1相
- Sylvester Comprehensive Cancer Center, Miami
他の都市における骨髄異形成症候群の試験
- Houston, TX43件の研究
- Baldwin Park, CA26件の研究
- New York City, NY21件の研究
- Seattle, WA21件の研究
- Washington, DC20件の研究
- Boston, MA19件の研究
- Tampa, FL19件の研究
- Columbus, OH14件の研究
- Durham, NC14件の研究
- Chicago, IL13件の研究
- Atlanta, GA13件の研究
- St. Louis, MO13件の研究
Miamiにおける他の研究
- 乳がん42件の研究
- がん（全種類）36件の研究
- 非小細胞肺癌31件の研究
- 前立腺がん27件の研究
- 肥満症27件の研究
- 急性骨髄性白血病24件の研究
- 転移性癌24件の研究
- 卵巣がん23件の研究
- 過体重23件の研究
- 多発性骨髄腫21件の研究
- 潰瘍性大腸炎21件の研究
- アルツハイマー病20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。